CIK 0000860730 · Large accelerated filer
HCA Healthcare, Inc.
Sign in to watch- Ticker
- HCA
- Exchange
- NYSE
- Industry
- Services-General Medical & Surgical Hospitals, NEC
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 273865930
- Phone
- 6153449551
- Business address
- ONE PARK PLZ, NASHVILLE, TN, 37203
- Former names
- HCA Holdings, Inc., HCA INC/TN, HCA THE HEALTHCARE CO, HCA-THE HEALTHCARE CO, COLUMBIA HCA HEALTHCARE CORP, COLUMBIA HCA HEALTHCARE CORP/, COLUMBIA HEALTHCARE CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $18,251,400
- in 3 filings
Net −$18,251,400. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-29 | McAlevey Michael R EVP & Chief Legal & Admin Off. | Grant or award · Stock Appreciation Right | +8,067 | 8,067 | ||
| 2026-01-29 | Marks Mike A EVP and CFO | Grant or award · Stock Appreciation Right | +11,945 | 11,945 | ||
| 2026-01-29 | HAZEN SAMUEL N CEO | Grant or award · Stock Appreciation Right | +55,846 | 55,846 | ||
| 2026-01-29 | Foster Jon M EVP and COO | Grant or award · Stock Appreciation Right | +11,945 | 11,945 | ||
| 2026-01-29 | Cuffe Michael S. EVP and Chief Clinical Officer | Grant or award · Stock Appreciation Right | +8,067 | 8,067 | ||
| 2026-01-29 | Berres Jennifer SVP & Chief Human Res. Officer | Grant or award · Stock Appreciation Right | +6,206 | 6,206 | ||
| 2025-11-14 | HAZEN SAMUEL N CEO | Gift | −14,830 | 32,276 | ||
| 2025-11-05 | McAlevey Michael R EVP & Chief Legal & Admin Off. | Sale | −3,892 | $473.79 | $1.8M | 3,487 |
| 2025-11-05 | Marks Mike A EVP and CFO | Gift | −165 | 0 | ||
| 2025-11-03 | McAlevey Michael R EVP & Chief Legal & Admin Off. | Option exercise | +13,170 | $236.61 | $3.1M | 16,657 |
| 2025-11-03 | McAlevey Michael R EVP & Chief Legal & Admin Off. | Shares withheld for taxes | −9,278 | $461.56 | $4.3M | 7,379 |
| 2025-11-03 | McAlevey Michael R EVP & Chief Legal & Admin Off. | Option exercise · Stock Appreciation Right | −13,170 | 0 | ||
| 2025-11-03 | Marks Mike A EVP and CFO | Gift | −165 | 43,240 | ||
| 2025-11-03 | Marks Mike A EVP and CFO | Gift | +165 | 165 | ||
| 2025-10-31 | HAZEN SAMUEL N CEO | Option exercise | +58,050 | $69.58 | $4.0M | 75,279 |
| 2025-10-31 | HAZEN SAMUEL N CEO | Shares withheld for taxes | −28,173 | $459.68 | $13.0M | 47,106 |
| 2025-10-31 | HAZEN SAMUEL N CEO | Option exercise · Stock Appreciation Right | −58,050 | 0 | ||
| 2025-09-08 | Cuffe Michael S. EVP and Chief Clinical Officer | Sale 10b5-1 | −3,836 | $418.84 | $1.6M | 31,502.9 |
| 2025-09-04 | Cuffe Michael S. EVP and Chief Clinical Officer | Option exercise 10b5-1 | +10,920 | $173.12 | $1.9M | 42,422.9 |
| 2025-09-04 | Cuffe Michael S. EVP and Chief Clinical Officer | Shares withheld for taxes 10b5-1 | −7,084 | $411.59 | $2.9M | 35,338.9 |
Page 6 of 56 · 1,102 trades